1. Home
  2. BIO vs RMBS Comparison

BIO vs RMBS Comparison

Compare BIO & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$361.29

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Logo Rambus Inc.

RMBS

Rambus Inc.

N/A

Current Price

$84.45

Market Cap

10.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
RMBS
Founded
1952
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Semiconductors
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
10.5B
IPO Year
1994
1997

Fundamental Metrics

Financial Performance
Metric
BIO
RMBS
Price
$361.29
$84.45
Analyst Decision
Hold
Buy
Analyst Count
3
8
Target Price
★ $335.00
$140.57
AVG Volume (30 Days)
212.7K
★ 1.8M
Earning Date
11-04-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 142.61
27.88
EPS
N/A
★ 1.84
Revenue
★ $2,583,200,000.00
$707,630,000.00
Revenue This Year
N/A
$18.48
Revenue Next Year
$2.13
$20.50
P/E Ratio
★ N/A
$45.81
Revenue Growth
0.65
★ 27.13
52 Week Low
$236.73
$77.89
52 Week High
$396.23
$174.10

Technical Indicators

Market Signals
Indicator
BIO
RMBS
Relative Strength Index (RSI) 45.72 38.21
Support Level $350.29 $81.38
Resistance Level $391.87 $104.44
Average True Range (ATR) 11.53 5.23
MACD 1.14 -1.07
Stochastic Oscillator 38.10 12.98

Price Performance

Historical Comparison
BIO
RMBS

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About RMBS Rambus Inc.

Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.

Share on Social Networks: